LEXEO Therapeutics is a biotechnology company. Founded by Ronald G. Crystal in 2018LEXEO Therapeutics is backed by D1 Capital Partners, Janus Henderson Investors, Alexandria Venture Investments, Omega Funds, and CAM Capital and is headquartered in New York.